Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 234 | 123 | 203 | 311 | 496 |
| Cost of Goods | 17 | 13 | 12 | 16 | 39 |
| Gross Profit | 217 | 110 | 191 | 296 | 457 |
| Operating Expenses | 8,523 | 5,759 | 5,324 | 5,954 | 5,263 |
| Operating Income | -8,289 | -5,636 | -5,121 | -5,643 | -4,768 |
| Other Income | -544 | -346 | 778 | 0 | -4 |
| Pre-tax Income | -8,833 | -5,981 | -4,343 | -5,642 | -4,771 |
| Net Income Continuous | -8,833 | -5,981 | -4,343 | -5,642 | -4,771 |
| Net Income | $-8,833 | $-5,981 | $-4,343 | $-5,642 | $-4,771 |
| EPS Basic Total Ops | -0.31 | -0.21 | -0.15 | -0.15 | -0.29 |
| EPS Basic Continuous Ops | -0.31 | -0.21 | -0.15 | -0.15 | -0.29 |
| EPS Diluted Total Ops | -0.31 | -0.21 | -0.15 | -0.15 | -0.29 |
| EPS Diluted Continuous Ops | -0.31 | -0.21 | -0.15 | -0.15 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.21 | -0.15 | -0.23 | -0.29 |
| EBITDA(a) | $-8,287 | $-5,634 | $-5,119 | $-5,638 | $-4,763 |